Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor-Reference-Cited by-同舟云学术

Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor

Published:2014-09 Issue:1 Volume:88 Page:252-260
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Danhier Fabienne,Ucakar Bernard,Vanderhaegen Marie-Lyse,Brewster Marcus E.,Arien Tina,Préat Véronique

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference26 articles.

1. Nanonization strategies for poorly water-soluble drugs;Chen;Drug Discov. Today,2011

2. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery;Danhier;J. Control. Release,2010

3. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986

4. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation;Keck;Eur. J. Pharm. Biopharm.,2006

5. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery;Muller;Eur. J. Pharm. Biopharm.,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Entrectinib Nanosuspension: Quality by Design for Enhanced Oral Bioavailability and Minimized Fast-Fed Variability;BioNanoScience;2024-05-29

2. Multifunctional nanocrystals for liver cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

3. Improved antileishmanial activity and cytotoxicity of a novel nanotherapy for N-iodomethyl-N,N-dimethyl-N-(6,6-diphenylhex-5-en-1-yl)ammonium iodide;Journal of Drug Delivery Science and Technology;2021-02

4. Development and solidification of multifunction stabilizers formulated self-assembled core-shell Deacetyl mycoepoxydience nanosuspensions;Journal of Molecular Liquids;2020-08

5. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability;AAPS PharmSciTech;2019-10-28